Introduction: When Medicine Looks Deeper
Genomics:Before his second birthday, a boy in Wisconsin named Nic Volker developed a severe bowel disease. Doctors ran test after test and performed more than 100 surgeries, yet no one could name the illness.
Then a team at the Medical College of Wisconsin and Children’s Hospital of Wisconsin tried something new at the time. They read the protein coding parts of all his genes, a method called whole exome sequencing. They found a change in a gene called XIAP. That gene had been linked to a serious blood and immune disorder, not to bowel disease, and that disorder can be treated with a bone marrow transplant. Nic received a cord blood transplant, and his doctors reported cautious optimism. The case was published in Genetics in Medicine in December 2010.
This is a true story, but it is one story. It does not mean every mystery illness hides a genetic answer. It does show why the same disease can behave differently in different people, and why a treatment that helps one patient may fail another.
Precision medicine tries to account for those differences. Genomics, the study of a person’s full set of genes, is one of its most powerful tools.
Table of Contents
What Is Precision Medicine?
The National Human Genome Research Institute describes precision medicine as an approach that uses a person’s genomic, environmental, and lifestyle information to guide medical decisions, aiming for more precise prevention, diagnosis, and treatment.
You will often hear “personalised medicine” used for the same idea. The terms overlap. Expert bodies preferred “precision” because “personalised” can suggest a treatment built for one individual. In practice, the goal is to work out which approach suits which patients.
Several kinds of evidence feed into one decision:
- Genes and DNA: the inherited instructions in your cells.
- Biomarkers: measurable signals, such as a gene change or a protein level, that hint at what a disease is doing.
- Clinical history: symptoms, past illness, family history, and test results.
- Lifestyle and environment: diet, activity, smoking, infections, and exposures.
Think of DNA as a huge recipe book. Owning the book does not tell you which recipes your kitchen is using today or who is coming to dinner. Doctors need that context too. The analogy is a teaching aid, not scientific proof.
Here is the first key point: precision medicine is more than reading DNA. A genome is a list of possibilities. Medicine begins when those possibilities are interpreted alongside the patient.
How Genomics Makes a Difference
Genomics studies all of a person’s genes and how they work together. Scientists look for changes, called variants, that are linked to a disease or to how someone responds to a medicine.
In good practice, the process has five steps:
- A clinician identifies a clear medical question.
- A suitable test or sequencing method is considered.
- Results are read alongside the patient’s history and other evidence.
- A qualified team decides whether the findings could change diagnosis, risk assessment, treatment, or follow up.
- The patient receives counselling and a management plan.
Two cautions matter. A variant does not automatically mean disease, because many are harmless and some are uncertain. And not every variant is inherited. Inherited (germline) variants are present from birth, while acquired (somatic) changes arise during life, including those found only in cancer cells.
Precision Medicine Versus Traditional Treatment
| Conventional approach | Precision medicine | |
|---|---|---|
| Aim | Treat the typical patient using proven guidelines | Match the approach to a patient subgroup |
| Information used | Symptoms, examination, standard tests, history | The same, plus genomic data or biomarkers when relevant |
| Strengths | Well tested, widely available, often cheaper | Can explain unusual cases and guide selected treatments |
| Limits | May treat different patients alike | Costly, results can be uncertain, evidence is uneven |
| Best fit | Common conditions with reliable standard care | Rare disease, some cancers, certain drug choices |
Precision medicine does not replace standard care. Many treatments work well without any genomic test, and a test is useful only when its result can inform a decision.
A genetic association is only a lead. Showing that a treatment helps a particular patient requires evidence from patients.
Real World Applications
Cancer care. Biomarker testing looks for changes in a tumour that may point to a targeted treatment. The National Cancer Institute notes that results can also show a therapy is unlikely to work. For example, HER2 testing helps show whether HER2 targeted therapy is likely to help a cancer. A match is a good sign, not a guarantee.
Pharmacogenomics. This field studies how genes affect response to medicines. The FDA keeps a table of drugs whose labels carry genetic information. A well known case is abacavir, an HIV medicine, where testing for a variant called HLA-B*57:01 is part of safe prescribing. For most medicines, no such test exists.
Rare diseases. Nic’s story shows how sequencing can end a long search, though not for every patient.
Inherited cancer risk. Variants in BRCA1 and BRCA2 raise the risk of breast and ovarian cancer. Testing with proper counselling can guide screening and prevention. A result describes risk, not destiny.
Complex diseases. In conditions such as heart disease or type 2 diabetes, genes work alongside lifestyle and environment. A gene report alone rarely settles an individual’s care.
The Five Questions Before a Genomic Test
Use these when talking with a doctor:
- What specific medical question is the test meant to answer?
- Could the result change treatment, monitoring, diagnosis, or family counselling?
- What are the limits, and what uncertain findings could appear?
- How will privacy, consent, and unexpected results be handled?
- Who will explain the result and help with next steps?
Testing should be chosen with a qualified healthcare professional. A consumer genetic report is not a medical diagnosis.
The Promise and the Limits
The promise is real: more informed treatment choices, better diagnosis in selected cases, and a clearer view of biological differences between people.
The limits are real too:
- Testing can be costly and hard to access.
- Genomic research has not represented all populations equally, so some results are less certain for some groups.
- Findings can be uncertain or unexpected.
- Data privacy matters, and protection against genetic discrimination depends on where you live.
- Genetic counselling is not available to everyone.
Common misconception: “If I know my genes, I know my future.” Most variants shift risk. They do not fix outcomes. Health also reflects social, environmental, and behavioural factors. Precision medicine is not a guaranteed cure, and not every patient needs sequencing.
What the Evidence Really Tells Us
Relative versus absolute risk. Commonly cited estimates say about 12 to 13 in 100 women in the general population develop breast cancer by age 70, compared with roughly 45 to 65 in 100 women carrying a BRCA1 or BRCA2 variant. Ranges differ by gene, study, and family history, so check the current NCI fact sheet and MedlinePlus guidance. The relative risk is several times higher, yet the absolute risk is still well below 100 in 100. That is why counselling matters more than a single number.
A reality check from drug labels. A 2014 analysis in the journal Pharmacogenomics examined FDA labels. It found genetic information on about 12% of drugs licensed from 1998 to 2012, but labels directed testing before prescribing in only 14 cases. The author concluded that, in most cases, the information had limited or no direct clinical use at that time. It looked at labels, not patient outcomes, and it is dated. Its lesson still holds: a laboratory finding is not the same as a better outcome.
Conclusion: Better Decisions, Not Genetic Predictions
Nic Volker’s doctors did not find magic. They asked a precise question, used the right test, and read the answer in clinical context.
Genomics can make healthcare more informed, but only with careful interpretation, sound clinical judgement, genuine consent, and fair access.
Your next step: if a genetic test is suggested for you or your family, ask the five questions above and discuss its purpose and limits with a qualified healthcare professional before you decide.
Frequently Asked Questions
What is precision medicine in simple words? Healthcare that uses a person’s genes, environment, lifestyle, and history to guide prevention, diagnosis, or treatment.
How does genomics help precision medicine? It finds gene changes linked to disease or drug response, which doctors weigh with other medical information.
Is precision medicine the same as genetic testing? No. Genetic testing is one tool among several, including biomarkers and clinical history.
Can genomic testing predict every disease? No. Most variants change risk rather than decide outcomes.
Is precision medicine useful for cancer treatment? Yes, in selected cases. Tumour biomarker tests can match some patients to targeted therapies, but not every cancer has one.
What should someone know before taking a genetic test? Know what it answers, what it cannot show, how your data is protected, and who will explain the results.
Disclaimer: This article is for general education. It does not give individual medical advice. Please consult a qualified healthcare professional about personal health decisions.